1-3 of 3
Kathleen Mendoza, RN
Close
Sort by
Journal Articles

Phase I/II Trial of the Efficacy and Safety of Combination Therapy with Lenalidomide/Bortezomib/Dexamethasone (RVD) and Panobinostat in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma

Jatin J. Shah, MD, Lei Feng, MS, Elisabet E. Manasanch, MD, Donna Weber, MD, Sheeba K Thomas, MD, Francesco Turturro, MD, Nina Shah, MD, Uday R. Popat, MD, Yago Nieto, MD PhD, Qaiser Bashir, MD, Silvia C Munoz, RN, Ashley Landry, RN, Kathleen Mendoza, RN, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD, Robert Z. Orlowski, PhD, MD
Journal: Blood
Blood (2015) 126 (23): 187.
https://doi.org/10.1182/blood.V126.23.187.187
Published: 2015
Journal Articles

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor Filanesib + Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Jatin J. Shah, MD, Lei Feng, MS, Sheeba K. Thomas, MD, Donna Weber, MD, Michael Wang, MD, Elisabet E. Manasanch, MD, Kathleen Mendoza, RN, Robert Z. Orlowski, PhD, MD
Journal: Blood
Blood (2015) 126 (23): 376.
https://doi.org/10.1182/blood.V126.23.376.376
Published: 2015
Journal Articles

Phase II Study of the Combination of Ixazomib with Lenalidomide As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Jatin J. Shah, MD, Lei Feng, MS, Donna Weber, MD, Sheeba K Thomas, MD, Michael Wang, MD, Francesco Turturro, MD, Muzaffar H. Qazilbash, MD, Nina Shah, MD, Qaiser Bashir, MD, Uday R. Popat, MD, Elisabet E. Manasanch, MD, Silvia C Munoz, RN, Ashley Landry, RN, Kathleen Mendoza, RN, Yago Nieto, MD PhD, Richard E. Champlin, MD, Robert Z. Orlowski, PhD, MD
Journal: Blood
Blood (2015) 126 (23): 3155.
https://doi.org/10.1182/blood.V126.23.3155.3155
Published: 2015